Simultaneous multi-pathway inhibition

Low toxicity permits high payload > 600mg/m2

Synergy with multiple mAbs

Overcoming late-stage, solid,
drug-resistant tumors with novel
multi-functional small molecules

Contact Us Now

that simultaneously inhibit multiple targets, to safely overcome
the urgent and unsolved problem of multi-drug resistance
without myelosuppression or GI effects while also stimulating
target antigen expression to enhance immunotherapy

We develop cancer drugs

Contact Us Now

Neovia’s Lead Compound

a combination small molecule consisting of
structurally redesigned derivatives of irinotecan
and etoposide with a stabilizing linker.


Learn more about NEV-801

Send us a Message
Visit our Location

Regus – Washington, Bellevue – Bellevue Skyline Tower

Neovia has global chemical-composition & use patents

USA, PCT, & China composition and use patents through 2038

Companies and Institutions Behind Our Success



ANU Pharmaceutical Company is an incubator company for the early-stage development of novel oncology compounds.

PUMC Pharmaceutical is a specialty pharmaceutical company.Since 1995, we have been working closely with the Peking Union Medical College (PUMC), the Chinese Ministry of Health and our international partners to meet the unmet medical needs of patients in China and around the world.

Prevail InfoWorks is a system integration and analytics software company with a unique combination of clinical expertise and engineering prowess. Providing best in Class Modular Technology for Improved Timelines and early observations in clinical trials. Prevail is managing Neovia’s first-in-human trial for NEV-801

The University of Iowa Pharmaceuticals has been manufacturing and testing pharmaceutical products in compliance with cGMPs for over 40 years. UIP provides contract pharmaceutical formulation development, clinical supply, and commercial manufacturing and analytical testing services for Neovia


Our People

Trevor Blake

Trevor Blake

Founder & CEO.

Since 2003 Trevor has founded and managed companies dedicated to developing and commercializing treatments for orphan-status diseases. He sold his...

Raymond Su

Raymond Su

Co-founder, President PUMC Pharmaceutical

Since 1973, Raymond has founded companies involved in health care, high technology, investment banking, real estate, and manufacturing across the...

Li-Xi Yang M.D., Ph,D

Li-Xi Yang M.D., Ph,D

Scientific Advisor

Dr Yang is Senior Scientist and Scientific Director of an integrated citywide graduate medical education program in radiation oncology at...

Gerald Su

Gerald Su

Chief Operating Officer

Previously, Gerald worked in New York, London, San Francisco and Washington D.C. in various finance and strategy positions, including as...